Acute myeloid leukemia

Acute myeloid leukemia overview

You are at the center of everything we do at Seattle Cancer Care Alliance (SCCA). Here, we surround you with a team of specialists who work together closely to provide expertly targeted, complete care and compassionate support throughout your treatment and beyond.

We guide you every step of the way, combining our deep clinical expertise in acute myeloid leukemia (AML) with a commitment to meet your unique needs.

Questions

phone (855) 557-0555
Call to request an appointment, refer a patient, or learn more about SCCA

Why choose SCCA?

  • Comprehensive AML treatment
    Our doctors are experts in the highly complex treatment AML requires. Based on the specific features of your disease, your team may recommend chemotherapy, bone marrow transplant or medicines used for the subtype acute promyelocytic leukemia (APL) specifically, all available at SCCA.

  • AML clinical studies
    To give you access to the most innovative therapies, SCCA unites the leading researchers and cancer specialists of Fred Hutch and UW Medicine so you can take part in AML clinical studies not available everywhere.

  • Pioneering new approaches
    Researchers here were the first to treat APL without chemotherapy, an approach now used worldwide. We are advancing AML chemotherapy and immunotherapy and use of diagnostic tools like UW-OncoPlex to guide treatment decisions.

  • Bone marrow transplant transplant for AML
    The Fred Hutch Bone Marrow Transplant Program at SCCA consistently achieves higher-than-expected transplant survival rates. We’ve performed more bone marrow transplants than any other institution in the world.

  • A national leader in cancer care
    SCCA is the leading cancer treatment center in the region and among the top nationally, according to U.S. News & World Report

  • Magnet Hospital Award
    University of Washington Medical Center, where our patients receive hospital-based care, has been honored as a Magnet hospital for excellence in nursing, which is linked to better outcomes for patients. 

  • NCI comprehensive cancer center
    We are a comprehensive cancer center, a designation from the National Cancer Institute that reflects our scientific leadership and the depth and breadth of our research to prevent, diagnose and treat cancer.

Treatment

Our doctors are experts in the highly complex treatment AML requires. Based on the specific features of your disease, your team may recommend chemotherapy, bone marrow transplant or medicines used for the subtype acute promyelocytic leukemia (APL) specifically, all available at SCCA.

Providers

At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.

Clinical trials

Seattle Cancer Care Alliance (SCCA) was formed, in part, to bring promising new treatments to patients faster. For acute myeloid leukemia patients, this means more treatment options at SCCA than you might find elsewhere, including the chance to participate in one of many ongoing clinical trials conducted at SCCA and its partner organizations, Fred Hutch and UW Medicine.